Viewing Study NCT05147558


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-01-01 @ 11:26 PM
Study NCT ID: NCT05147558
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-26
First Post: 2021-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module